Results 161 to 170 of about 4,926 (176)

Long-term efficacy of docosahexaenoic acid (DHA) for Spinocerebellar Ataxia 38 (SCA38) treatment: An open label extension study

Parkinsonism and Related Disorders, 2019
Barbara Borroni, Enrico Premi, Nico Mitro   +2 more
exaly  

Alteration of methylation status in the ATXN3 gene promoter region is linked to the SCA3/MJD

Neurobiology of Aging, 2017
Kun Xia, Qian Xu, Xin Zhou
exaly  

T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse

Neuropharmacology, 2015
Tu-Hsueh Yeh, An Hsun Chou, Ching-Chi Chiu   +2 more
exaly  

Late Onset Spinocerebellar Ataxia: SCA3

2017
openaire   +1 more source

Spinocerebellar ataxia, type 3 (SCA3) is genetically identical to Machado-Joseph disease (MJD)

Journal of the Neurological Sciences, 1995
Ulrich Müller, Frank Leweke
exaly  

Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide

Molecular Therapy - Nucleic Acids, 2019
Anchel González-Barriga, Nicole Datson, Eleni Kourkouta   +2 more
exaly  

SCA3

openaire   +1 more source

HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3

Neurobiology of Disease, 2011
Tu-Hsueh Yeh, An Hsun Chou, Hung-Li Wang   +2 more
exaly  

Tremulous SCA3: The Complex Connection between the Cerebellum and Basal Ganglia

The Cerebellum
Victor Rebelo Procaci, Raphael Pinheiro Camurugy da Hora, Orlando Graziani Povoas Barsottini, José Luiz Pedroso   +3 more
openaire   +2 more sources

Intrafamilial variability of Parkinson phenotype in SCAs: Novel cases due to SCA2 and SCA3 expansions

Parkinsonism and Related Disorders, 2009
Laura Bannach Jardim, CARLOS Roberto De Mello Rieder, Maria-Luiza Saraiva-Pereira   +2 more
exaly